bluebird bio Inc. (BLUE)
NASDAQ: BLUE
· Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM
bluebird bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -29.07M | -28.71M | -60.81M | -81.39M | -69.8M | -88.51M | -71.73M | -72.91M | 21.24M | 32.23M | -76.52M | -100.14M | -122.15M | -155.05M | -216.82M | -241.7M | -205.81M |
Depreciation & Amortization | 15.54M | 13.9M | 15.34M | 16.53M | 15.47M | 25.4M | 1.07M | 970K | 1.08M | 1.26M | 1.39M | 1.34M | 1.01M | 2.31M | 5.98M | 5.99M | 5.36M |
Stock-Based Compensation | 1.66M | 4.07M | 2.7M | 3.21M | 3.76M | 3.42M | 4.87M | 5.75M | 5.39M | 4.68M | 9.21M | 8.91M | 12.39M | 26.09M | 28.14M | 31.16M | 42.53M |
Other Working Capital | n/a | -50.77M | -26.71M | -41.12M | n/a | n/a | 8.29M | -2.85M | -11.86M | -7.61M | -6.96M | -1.93M | -29.23M | -886K | -1.89M | -314K | -2.51M |
Other Non-Cash Items | n/a | 15.93M | 4.03M | 12.61M | 6.05M | 66.21M | -324K | 106K | -92.47M | -100.99M | 2.23M | 1.1M | 10.22M | 3.8M | 7.18M | 3.76M | 2.88M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 1.39M | 3.71M | n/a | n/a | n/a | n/a | n/a | -379K | 14.15M | 15.17M | -28.37M |
Change in Working Capital | n/a | -55.35M | -30.2M | -17.2M | -29.47M | -20.35M | 2.88M | -10.36M | -21.89M | 6.55M | -13.33M | -5.57M | -26.76M | -16.49M | 14.43M | 39.97M | -19.92M |
Operating Cash Flow | -43.44M | -50.16M | -68.93M | -66.25M | -74.68M | -13.84M | -61.85M | -72.72M | -86.64M | -56.27M | -77.03M | -94.36M | -125.3M | -139.72M | -146.94M | -145.65M | -203.33M |
Capital Expenditures | -859K | -485K | -280K | -59K | -1.77M | -5.21M | -2.04M | -705K | -1.1M | -5.11M | -1.26M | -5.98M | -857K | -2.06M | -9.74M | -3.58M | -7.63M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -64.12M | n/a | n/a | n/a | n/a | n/a | n/a | 500K | 6M | 2M | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -8.88M | -14.81M | -19.61M | n/a | n/a | n/a | n/a | -29.98M | -225.27M | -142.94M | -53.2M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 9M | 73M | 22.5M | 9.87M | 6.35M | 16.87M | 67.66M | 70.78M | 92.97M | 244.62M | 206.89M | 382.18M |
Other Investing Acitivies | 3.96M | 2.95M | 746K | 1.68M | 1.12M | -4M | 64.12M | -42K | 92.97M | 102M | 16.87M | 67.66M | 70.78M | -500K | 104.3M | -2M | 328.98M |
Investing Cash Flow | 3.1M | 2.46M | 466K | 1.62M | -655K | 3.79M | 62.08M | 6.95M | 82.14M | 103.24M | 15.61M | 61.68M | 69.93M | 60.93M | 119.91M | 60.37M | 321.35M |
Debt Repayment | n/a | -16.37M | -20.93M | -26.43M | 49.11M | n/a | n/a | -13.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -196K | -131K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 54.73M | 51.36M | 14.83M | 20.37M | 15.54M | -51.85M | 8K | 78K | 7K | n/a | 3K | -9K | 9K | -174.01M | 886K | 396K | 3.8M |
Financial Cash Flow | 26.71M | 34.99M | -6.11M | -6.06M | 64.64M | 66.28M | -42K | -445K | 130.46M | -115K | 46.33M | 8.03M | 9K | -174.01M | 75.87M | 396K | 3.8M |
Net Cash Flow | -13.63M | -12.71M | -74.57M | -70.69M | -10.69M | 56.23M | 195K | -66.22M | 125.95M | 46.85M | -15.09M | -24.65M | -55.36M | -252.81M | 48.83M | -84.88M | 121.82M |
Free Cash Flow | -44.3M | -50.65M | -69.21M | -66.31M | -76.45M | -19.05M | -63.88M | -73.43M | -87.74M | -61.38M | -78.29M | -100.34M | -126.15M | -141.78M | -156.68M | -149.23M | -210.95M |